NO20051282L - Antitumorale analoger av lamellariner. - Google Patents

Antitumorale analoger av lamellariner.

Info

Publication number
NO20051282L
NO20051282L NO20051282A NO20051282A NO20051282L NO 20051282 L NO20051282 L NO 20051282L NO 20051282 A NO20051282 A NO 20051282A NO 20051282 A NO20051282 A NO 20051282A NO 20051282 L NO20051282 L NO 20051282L
Authority
NO
Norway
Prior art keywords
lamellarins
antitumoral
analogs
antitumoral analogs
stereoisomer
Prior art date
Application number
NO20051282A
Other languages
English (en)
Norwegian (no)
Inventor
Carmen Cuevas Marchante
Christian Bailly
Andres Francesch Solloso
Maria Cristina Mateo Urbano
Jose Antonio Jimenez Guerrero
Alfredo Pastor Del Castillo
Original Assignee
Pharma Mar Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sau filed Critical Pharma Mar Sau
Publication of NO20051282L publication Critical patent/NO20051282L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20051282A 2002-08-13 2005-03-10 Antitumorale analoger av lamellariner. NO20051282L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0218816.7A GB0218816D0 (en) 2002-08-13 2002-08-13 Antitumoral analogs of lamellarins
PCT/GB2003/003541 WO2004014917A2 (en) 2002-08-13 2003-08-13 Antitumoral analogs of lamellarins

Publications (1)

Publication Number Publication Date
NO20051282L true NO20051282L (no) 2005-05-11

Family

ID=9942234

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051282A NO20051282L (no) 2002-08-13 2005-03-10 Antitumorale analoger av lamellariner.

Country Status (17)

Country Link
US (1) US7396837B2 (xx)
EP (2) EP1551844B1 (xx)
JP (1) JP2005536529A (xx)
KR (1) KR20050053613A (xx)
CN (2) CN101941977A (xx)
AT (1) ATE475663T1 (xx)
AU (1) AU2003252997B2 (xx)
CA (1) CA2493725A1 (xx)
DE (1) DE60333578D1 (xx)
GB (1) GB0218816D0 (xx)
HK (1) HK1078580A1 (xx)
IL (1) IL166513A0 (xx)
MX (1) MXPA05001731A (xx)
NO (1) NO20051282L (xx)
NZ (1) NZ537935A (xx)
RU (1) RU2328500C2 (xx)
WO (1) WO2004014917A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071587B2 (en) 2009-05-27 2011-12-06 N. V. Organon (Dihydro)imidazoiso[5,1-A]quinolines
TW201116531A (en) 2009-07-29 2011-05-16 Organon Nv Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
US8431564B2 (en) 2009-07-29 2013-04-30 Merck Sharp & Dohme B.V. Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
WO2011035417A1 (en) * 2009-09-25 2011-03-31 Aegera Therapeutics Inc. Hsp-90 binding compounds, compositions thereof, and their use fn the treatment of autoimmune and inflammatory diseases
JP5888702B2 (ja) * 2011-01-17 2016-03-22 国立大学法人 長崎大学 抗癌活性化合物
WO2012126084A1 (en) * 2011-03-24 2012-09-27 Pharmascience Inc. Hsp-90 binding compounds, compositions thereof, and their use iν the treatment and prevention of fungal infections
KR101721029B1 (ko) * 2014-10-16 2017-03-29 연세대학교 산학협력단 인돌리지노[3,2-c]퀴놀린 유도체, 이의 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 낭포성 섬유증 예방 또는 치료용 약학조성물
TWI674265B (zh) * 2017-03-27 2019-10-11 東海大學 片螺素及其衍生物之製造方法
US11286261B2 (en) 2017-03-29 2022-03-29 Nagasaki University Fourth-generation EGFR tyrosine kinase inhibitor
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN112300232B (zh) * 2020-11-03 2021-11-09 浙江大学 Lamellarin D糖基化衍生物及其制备和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852033A (en) * 1995-06-29 1998-12-22 Pharma Mar, S.A. Methods of treatment using lamellarin-class alkaloids
AUPO656597A0 (en) * 1997-05-02 1997-05-29 Australian National University, The Preparation of therapeutic compounds
AUPP433398A0 (en) * 1998-06-25 1998-07-16 Australian National University, The Compounds and processes

Also Published As

Publication number Publication date
JP2005536529A (ja) 2005-12-02
EP2138496A1 (en) 2009-12-30
US20060173030A1 (en) 2006-08-03
MXPA05001731A (es) 2005-08-16
EP1551844A2 (en) 2005-07-13
KR20050053613A (ko) 2005-06-08
WO2004014917A3 (en) 2004-05-13
WO2004014917A2 (en) 2004-02-19
AU2003252997A1 (en) 2004-02-25
RU2005106863A (ru) 2005-11-10
IL166513A0 (en) 2006-01-15
ATE475663T1 (de) 2010-08-15
AU2003252997B2 (en) 2009-08-06
US7396837B2 (en) 2008-07-08
CN101941977A (zh) 2011-01-12
DE60333578D1 (de) 2010-09-09
EP1551844B1 (en) 2010-07-28
CN1688585A (zh) 2005-10-26
CA2493725A1 (en) 2004-02-19
NZ537935A (en) 2007-02-23
RU2328500C2 (ru) 2008-07-10
HK1078580A1 (en) 2006-03-17
GB0218816D0 (en) 2002-09-18

Similar Documents

Publication Publication Date Title
NO20051282L (no) Antitumorale analoger av lamellariner.
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
DE69830504D1 (de) Antithrombotische mitteln
CY1111693T1 (el) Αντιιικοι παραγοντες
DOP2002000456A (es) Inhibidores de la alquin-aril fosfodiesterasa-4''
MY134129A (en) Polymorphs of an epothilone analog
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MY140987A (en) Specific glucocorticosteroid compound having anti-inflammatory activity
EP2266623A3 (en) Prodrugs containing novel bio-cleavable linkers
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
ATE306261T1 (de) Antithrombosemittel
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
NO20040881L (no) Orale antidiabetes midler.
IL169257A0 (en) Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents
AU2001286768A1 (en) Novel macrocycles and uses thereof
WO2005077926A3 (en) Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease
PT992509E (pt) Novos derivados macrolidos
SE0102055D0 (sv) New Compounds
MY138826A (en) 2,7-substituted indoles
DE60114640D1 (en) Antithrombosemittel
WO2003101996A3 (en) Esters in position 20 of camptothecins
GB0212410D0 (en) Organic compounds
MXPA04005988A (es) 3,4-dihidro-1h-isoquinolin-2-il-derivados.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application